258 related articles for article (PubMed ID: 15277315)
1. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.
Akerman S; Kaube H; Goadsby PJ
Br J Pharmacol; 2004 Aug; 142(8):1354-60. PubMed ID: 15277315
[TBL] [Abstract][Full Text] [Related]
2. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception.
Akerman S; Kaube H; Goadsby PJ
J Pharmacol Exp Ther; 2004 Apr; 309(1):56-63. PubMed ID: 14718591
[TBL] [Abstract][Full Text] [Related]
3. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
4. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
Akerman S; Kaube H; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
[TBL] [Abstract][Full Text] [Related]
5. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
6. Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig.
Nicoletti P; Trevisani M; Manconi M; Gatti R; De Siena G; Zagli G; Benemei S; Capone JA; Geppetti P; Pini LA
Cephalalgia; 2008 Jan; 28(1):9-17. PubMed ID: 17888011
[TBL] [Abstract][Full Text] [Related]
7. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
8. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
9. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
Akerman S; Williamson DJ; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
[TBL] [Abstract][Full Text] [Related]
10. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
11. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
12. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
[TBL] [Abstract][Full Text] [Related]
13. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
[TBL] [Abstract][Full Text] [Related]
14. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
[TBL] [Abstract][Full Text] [Related]
15. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Br J Pharmacol; 2002 Sep; 137(1):62-8. PubMed ID: 12183331
[TBL] [Abstract][Full Text] [Related]
18. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
Andreou AP; Holland PR; Goadsby PJ
Br J Pharmacol; 2009 Jun; 157(3):464-73. PubMed ID: 19309356
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
20. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats.
Orliac ML; Peroni RN; Abramoff T; Neuman I; Podesta EJ; Adler-Graschinsky E
Eur J Pharmacol; 2007 Jul; 566(1-3):145-52. PubMed ID: 17482593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
